BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Murphy CE, Walker AK, Weickert CS. Neuroinflammation in schizophrenia: the role of nuclear factor kappa B. Transl Psychiatry 2021;11:528. [PMID: 34650030 DOI: 10.1038/s41398-021-01607-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Burke T, Gleeson C, Holleran L, Mothersill D, Holland J, Costello L, Kane R, Mckernan DP, Morris DW, Kelly JP, Corvin AP, Hallahan BP, Mcdonald C, Donohoe G. Corpus Callosum Microstructural Tract Integrity Relates to Longer Emotion Recognition Reaction Time in People with Schizophrenia. Brain Sciences 2022;12:1208. [DOI: 10.3390/brainsci12091208] [Reference Citation Analysis]
2 Mou TM, Lane MV, Ireland DDC, Verthelyi D, Tonelli LH, Clark SM. Association of complement component 4 with neuroimmune abnormalities in the subventricular zone in schizophrenia and autism spectrum disorders. Neurobiol Dis 2022;173:105840. [PMID: 35995342 DOI: 10.1016/j.nbd.2022.105840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Markiewicz-Gospodarek A, Markiewicz R, Dobrowolska B, Maciejewski R, Łoza B. Relationship of Neuropeptide S with Clinical and Metabolic Parameters of Patients during Rehabilitation Therapy for Schizophrenia. Brain Sci 2022;12:768. [PMID: 35741653 DOI: 10.3390/brainsci12060768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Smigielski L, Stämpfli P, Wotruba D, Buechler R, Sommer S, Gerstenberg M, Theodoridou A, Walitza S, Rössler W, Heekeren K. White matter microstructure and the clinical risk for psychosis: A diffusion tensor imaging study of individuals with basic symptoms and at ultra-high risk. Neuroimage Clin 2022;35:103067. [PMID: 35679786 DOI: 10.1016/j.nicl.2022.103067] [Reference Citation Analysis]
5 Morris G, Sominsky L, Walder KR, Berk M, Marx W, Carvalho AF, Bortolasci CC, Maes M, Puri BK. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia. Mol Neurobiol 2022. [PMID: 35347586 DOI: 10.1007/s12035-022-02800-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Vallée A. Neuroinflammation in Schizophrenia: The Key Role of the WNT/β-Catenin Pathway. Int J Mol Sci 2022;23:2810. [PMID: 35269952 DOI: 10.3390/ijms23052810] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Luís JP, Simões CJV, Brito RMM. The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. Int J Mol Sci 2022;23:1731. [PMID: 35163653 DOI: 10.3390/ijms23031731] [Reference Citation Analysis]
8 li Y, jinxiang T, shu Y, yadong P, ying L, meng Y, Ping Z, xiao H, xiao F. Childhood trauma and the plasma levels of IL-6, TNF-α are risk factors for major depressive disorder and schizophrenia in adolescents: a cross-sectional and case-control study. Journal of Affective Disorders 2022. [DOI: 10.1016/j.jad.2022.02.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? Postgrad Med 2021;:1-13. [PMID: 34766870 DOI: 10.1080/00325481.2021.2006514] [Reference Citation Analysis]